Drug Prices:How Much Is Too much?
March 27th, 2007
An interesting debate has broken out amongst drug companies, policy makers and patients on new cancer drugs which can extend life for a few months but are horribly expensive.
On Tuesday, the Food and Drug Administration approved GlaxoSmithKline’s Tykerb, a once-a-day pill for late-stage breast cancer patients that costs nearly $35,000 a year. It’s the [...]